Intra-Cellular Therapies (ITCI) is set to release its quarterly earnings report on Wednesday, October 30th. Analysts anticipate an EPS of -$0.19. This article delves into key metrics, analyst sentiment, and peer comparisons to help investors understand the company’s current trajectory and potential future performance.
Intra-Cellular Therapies (ITCI) is set to release its quarterly earnings report on Wednesday, October 30th. Analysts anticipate an EPS of -$0.19. This article delves into key metrics, analyst sentiment, and peer comparisons to help investors understand the company’s current trajectory and potential future performance.
